In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
As of close of business last night, Adaptive Biotechnologies Corp’s stock clocked out at $16.68, down -0.42% from its previous closing price of $16.75. In other words, the price has decreased by -$0.42 from its previous closing price. On the day, 0.91 million shares were traded. ADPT stock price reached its highest trading level at $16.77 during the session, while it also had its lowest trading level at $16.33.
Ratios:
To gain a deeper understanding of ADPT’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.26 and its Current Ratio is at 3.38. In the meantime, Its Debt-to-Equity ratio is 1.05 whereas as Long-Term Debt/Eq ratio is at 0.99.
On September 30, 2025, Guggenheim started tracking the stock assigning a Buy rating and target price of $20.
On June 18, 2025, Craig Hallum started tracking the stock assigning a Buy rating and target price of $15.Craig Hallum initiated its Buy rating on June 18, 2025, with a $15 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Dec 15 ’25 when LO FRANCIS sold 113,890 shares for $15.57 per share. The transaction valued at 1,773,267 led to the insider holds 315,978 shares of the business.
FRANCIS LO bought 136,706 shares of ADPT for $2,110,741 on Dec 15 ’25. On Dec 10 ’25, another insider, HERSHBERG ROBERT, who serves as the Director of the company, sold 22,968 shares for $16.00 each. As a result, the insider received 367,488 and left with 46,722 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ADPT now has a Market Capitalization of 2546455296 and an Enterprise Value of 2547145216. For the stock, the TTM Price-to-Sale (P/S) ratio is 10.08 while its Price-to-Book (P/B) ratio in mrq is 12.45. Its current Enterprise Value per Revenue stands at 10.078 whereas that against EBITDA is -42.381.
Stock Price History:
The Beta on a monthly basis for ADPT is 2.17, which has changed by 1.6518283 over the last 52 weeks, in comparison to a change of 0.16098404 over the same period for the S&P500. Over the past 52 weeks, ADPT has reached a high of $20.76, while it has fallen to a 52-week low of $5.91. The 50-Day Moving Average of the stock is 0.60%, while the 200-Day Moving Average is calculated to be 37.24%.
Shares Statistics:
It appears that ADPT traded 2.32M shares on average per day over the past three months and 2314810 shares per day over the past ten days. A total of 152.58M shares are outstanding, with a floating share count of 146.78M. Insiders hold about 3.86% of the company’s shares, while institutions hold 94.05% stake in the company. Shares short for ADPT as of 1765756800 were 9742510 with a Short Ratio of 4.20, compared to 1763078400 on 10368382. Therefore, it implies a Short% of Shares Outstanding of 9742510 and a Short% of Float of 8.17.
Earnings Estimates
Investors are keenly observing as 7.0 analysts analyze and rate. The current performance of Adaptive Biotechnologies Corp (ADPT) in the stock market.The consensus estimate for the next quarter is -$0.17, with high estimates of -$0.15 and low estimates of -$0.19.
Analysts are recommending an EPS of between -$0.46 and -$0.51 for the fiscal current year, implying an average EPS of -$0.49. EPS for the following year is -$0.57, with 7.0 analysts recommending between -$0.51 and -$0.65.
Revenue Estimates
In. The current quarter, 7 analysts expect revenue to total $59.28M. It ranges from a high estimate of $61.5M to a low estimate of $57.7M. As of. The current estimate, Adaptive Biotechnologies Corp’s year-ago sales were $47.46MFor the next quarter, 7 analysts are estimating revenue of $59.3M. There is a high estimate of $63.1M for the next quarter, whereas the lowest estimate is $55.08M.
A total of 8 analysts have provided revenue estimates for ADPT’s current fiscal year. The highest revenue estimate was $266.8M, while the lowest revenue estimate was $263M, resulting in an average revenue estimate of $264.62M. In the same quarter a year ago, actual revenue was $178.96MBased on 8 analysts’ estimates, the company’s revenue will be $267.68M in the next fiscal year. The high estimate is $275.5M and the low estimate is $255.7M.
